	Correction to: Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study. J Neurooncol Buccilli B, Yoon J, Hussein A, Faraji AH. PMID: 41217607 [PubMed - in process]
	Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer. Future Sci OA Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Lohmann TO, Xu T, Cardona A, Hiles L, Noe J, Solomon BJ. PMID: 41217067 [PubMed - in process]
	Real-World Characteristics of U.S. Veterans Who Have Undergone Robot-Assisted Bronchoscopy to Diagnose Lung Cancer. J Bronchology Interv Pulmonol Peterson JA, Jaber JF, Mashina M, Korzhuk A, Eperjesiova B. PMID: 41216680 [PubMed - in process]
	Global Survey on Current Practices of Endobronchial Ultrasound Approaches to N2 Staging in Non-Small Cell Lung Cancer Following the Ninth Edition of the TNM Classification. J Bronchology Interv Pulmonol Kontogianni K, Bugalho A, Herth FJ, Höger P, Dittrich SA, Eichhorn F, Morand LC, Bostanci K, van der Heijden EHFM, Lee P, Annema JT, Eberhardt R, Trudzinski FC. PMID: 41216665 [PubMed - in process]
	The Cost of Lost Follow-Up: A Diagnosis of Sarcomatoid Lung Carcinoma Following a Presumed Benign Pulmonary Mass and the Necessity of a Physician's Suspicion. Cureus Moreno Gonzalez XA, Mcclaskey PG, Vu MK, Gogerdchian H, Murdande S, Dao KT, Bazmi A. PMID: 41216048 [PubMed - in process]
	Prediction of lung dose-volume parameters of the patients with esophageal cancer undergoing radiotherapy based on artificial neural network. J Appl Clin Med Phys Li F. PMID: 41215535 [PubMed - in process]
	Comparison of treatment outcomes between stereotactic body radiotherapy/proton beam therapy and sublobar resection for vulnerable elderly patients with stage IA non-small cell lung cancer. Jpn J Clin Oncol Asami M, Katsumata S, Yasui K, Yamaguchi D, Masuda T, Kojima H, Konno H, Isaka M, Harada H, Ohde Y. PMID: 41215492 [PubMed - as supplied by publisher]
	Fast Track Pathway for Lung Cancer: The Integration of ION Robotic-Assisted Bronchoscopy With Robotic Thoracic Surgical Resection. Surg Innov Guarize J, Bertolaccini L, Spaggiari L. PMID: 41214869 [PubMed - as supplied by publisher]
	Risk factors and predictive model of lymph node metastasis in clinical stage IA peripheral non-small cell lung cancer: a retrospective study. BMC Cancer Chen Z, Wang Y, Shi M, Qi K, Liu X, Zhang S. PMID: 41214551 [PubMed - in process]
	Molecular Mechanisms and Treatment Strategies of ALK-Positive Lung Cancer: A Beginner's Guide for Patients, Their Families and Carers. Thorac Cancer Klenova E. PMID: 41213866 [PubMed - in process]
	Specialist Palliative Care Reduces the Need for Acute Health Care Services in Patients with Nonmalignant Pulmonary Diseases and Lung Cancer: A Nationwide Study. J Palliat Med Pihlaja H, Piili RP, Nuutinen M, Saarto T, Lehto JT, Carpén T. PMID: 41213631 [PubMed - as supplied by publisher]
	Lung cancer biomarkers. Clin Chim Acta Mangang KN, Rao GSNK. PMID: 41213493 [PubMed - as supplied by publisher]
	Inequalities in the utilisation of curative-intent treatments for early-stage non-small cell lung cancer across urban and rural areas: A population-based study in England. J Cancer Policy Kagenaar E, Lugo-Palacios DG, Aggarwal A, Hutchings A, Han L, O'Neill S, Rachet B, Edwards J, Faivre-Finn C, Grieve R. PMID: 41213453 [PubMed - as supplied by publisher]
	Utilization of Lung Cancer Registries in Learning Health Systems for Health Care Improvement. JCO Clin Cancer Inform Stirling RG, Baldwin DR, Heineman D, Wouters MWJM, Navani N, Dawkins P, Melder A, Zalcberg J, Jakobsen E. PMID: 41213098 [PubMed - in process]
	Expression and Clinical Significance of MMP-1 and MMP-7 in Pneumonia, Pulmonary Fibrosis, and Lung Cancer. J Vis Exp Wang C, Fan X, Fang S, Tan F, Zhang Y, Duan X, Hu H, Wang X. PMID: 41212837 [PubMed - in process]
	Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer. Target Oncol Johnson ML, Dakhil SR, Beck JT, Sadiq A, Menon S, Mugundu GM, Chmielecki J, Spigel DR. PMID: 41212474 [PubMed - as supplied by publisher]
	A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab, lenvatinib, carboplatin and pemetrexed in patients with metastatic non-small cell lung cancer harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitors. Invest New Drugs Chan HW, Tse CCL, Li YC, Leung R, Kwok GW, Wong JSL, Li KH, Tsang JWY, Li CW, Lo JWY, Tang V, Hui R, Yau T, Ho JCM, Chiu JWY. PMID: 41212380 [PubMed - as supplied by publisher]
	First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. MedComm (2020) Du W, Li A, Xiao B, Yang Y, Fang W, Huang Y, Hong S, Zhang L. PMID: 41211184 [PubMed - in process]
	The Impact of Caregiving Intensity and Financial Burden on the Health-Related Quality of Life Among Informal Caregivers for Patients With Advanced Lung Cancer: A Multicenter Cross-Sectional Study. J Nurs Manag Yang Y, Deng Q, Liu L, Chen Y. PMID: 41211179 [PubMed - in process]
	Detection of Lung Cancer Biomarkers C(3)H(6)O, CH(2)O, and C(5)H(8) through Pdâ€‘, Ptâ€‘, and Ag-Doped BC(6)N Monolayers: A Density Functional Theory Study. ACS Omega Lai C, Luo X. PMID: 41210811 [PubMed - in process]

Articles 1 - 20 / 151457

Page 1 of 7573



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy